The Impact of Oral Contrast in Multidetector CT of the Abdomen and Pelvis on Radiologist Confidence
NCT ID: NCT01655550
Last Updated: 2012-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
216 participants
INTERVENTIONAL
2012-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesis: Oral contrast does not significantly affect the diagnostic confidence of interpreting radiologists in intravenously enhanced abdominal CT scans.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be randomized at the time of recruitment, which will be when he/she calls to make the appointment for the exam, in a 1:1 ratio between the control arm (contrast) and the experimental arm (no contrast). The control arm will either pick up their two bottles of oral contrast at a radiology office or have the bottles mailed to them as is currently the standard. They will drink the oral contrast two hours before the study. They will also ingest 300 mL of water immediately prior to imaging and be administered the standard intravenous contrast dose. The experimental group will not be mailed or given any oral contrast. They will arrive at their appointment and ingest 300 mL of water immediately prior to the exam as well as the standard intravenous contrast dose and be scanned. This design will eliminate the need to repeat scanning patients, thus decreasing radiation dose. A patient satisfaction survey will be given to each patient following the exam and handed to the technologist
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
Patients will get routine CT scans with Oral and Intravenous contrast prior to their CT scan as is routine, standard practice
Withhold oral contrast
The intervention is to withhold oral contrast
Withold Oral Contrast
Subjects will not drink oral contrast, but instead water (in itself a type of contrast agent) prior to their CT. Intravenous contrast will be administered as is routine
Withhold oral contrast
The intervention is to withhold oral contrast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Withhold oral contrast
The intervention is to withhold oral contrast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥21
* able and willing to give consent
Exclusion Criteria
* order for non-contrast CT
* \<21
* pregnant woman
* order for enterography or colonography
* history of Crohn's Disease or Ulcerative Colitis
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hartford Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher M Garcia, MD MHS
Role: PRINCIPAL_INVESTIGATOR
Hartford Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jefferson Radiology
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bret Coughlin, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GARC003501
Identifier Type: -
Identifier Source: org_study_id